1/27/2022 | 3002150000 | TISLELIZUMAB (BGB-A317), 100 mg/10 ml intravenous solution concentrate or placebo in vial - 18 vials, lot 234940010, EXPIRY DATE 02/19/2023 | 0.3 | 1261.31 | China | Unknown | PAREXEL INTERNATIONAL RUS LLC |
1/31/2022 | 3002908000 | .BLOOD FRACTIONS NOT FOR VETERINARY, FOR LABORATORY PURPOSES, REAGENTS FOR BIOCHEMICAL MEDICAL RESEARCH. IMPORT FOR THE PURPOSE OF STATE REGISTRATION AND SUBSEQUENT SALES IN ACCORDANCE WITH REGULATION OF THE GOVERNMENT OF THE RUSSIAN FEDERATION N 430 DATED 03.04.2020. TYPE CODE: | 12.03 | 3533 | South Korea | MOSCOW RUSSIA | ROSH DIAGNOSTIKA RUS LLC |
1/27/2022 | 3002150000 | MEDICINES IMPORTED UNDER PERMIT FOR TEMPORARY CIRCULATION IN ACCORDANCE WITH GOVERNMENT DECISION 441 DATED 03.04.20, RECOMBINANT HUMAN IGG1-KAPPA MONOCLONAL ANTIBODY: SOTROVIMAB (SOTROVIMAB) CONCENTRATE FOR PREPARATION | 95.55 | 4022691.9 | Italy | MOSCOW RUSSIA | GLAXOSMITHKLINE TRADING JSC |
1/10/2022 | 3002150000 | MEDICATIONS IN DOSAGE FORMS, NOT FOR VETERINARY, FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. M14-239 (PERMISSION OF THE MOH No. 51 DATED 01.02.2019) NOT FOR SALE OR RESALE | 0.4 | 1114.08 | Italy | SHEREMETIEVO 2 MOSCOW RUSSIA | COREKS ON ORDER OF THE REPRESENTATIVE OFFICE DR REDDY'S LABORATORIS LTD LLC |
1/24/2022 | 3002150000 | SAR153191 (SARILUMAB), SC SOLUTION 175 MG/ML IN 2.7 ML BOTTLE, 1 BOTTLE PER PACK, 200 BOTTLE TOTAL, SERIES IP025136, EXPIRY DATE 02/2023, : | 5.6 | 11811.5 | United States of America | Unknown | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/14/2022 | 3002150000 | MEDICINES IN DOSAGE FORMS, NOT FOR VETERINARY, FOR CLINICAL RESEARCH PROTOCOL NO. M15-572 (MINISTRY OF HEALTH AUTHORIZATION NO. 452 DATED 8/21/17) NOT FOR SALE OR RESALE | 7 | 59778.4 | Germany | SHEREMETIEVO 2 MOSCOW RUSSIA | COREKS ON ORDER OF THE REPRESENTATIVE OFFICE DR REDDY'S LABORATORIS LTD LLC |
1/14/2022 | 3002150000 | MEDICINE: SYD985 , LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR SOLUTION FOR INFUSION 80 MG PER VIAL, 12 VIALS PER PACK, 1 PACK TOTAL, EXPIRY DATE 06/30/2022, FOR CLINICAL STUDY | 0.36 | 2997.63 | Germany | ST PETERSBURG RUSSIA | PI ES AY LLC |